3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
5
NIH
3
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Sarcoma
5
Lymphoma
4
Leukemia
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Teratoma
2
Preleukemia
2
Precancerous Conditions
2
Neuroblastoma
2
Neoplasms by Histologic Type
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoproliferative Disorders
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphatic Diseases
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Central Nervous System Neoplasms
2
Brain Neoplasms
2
Bone Marrow Diseases
2
Recurrence
1
Primary Myelofibrosis
1
Osteosarcoma
1
Interventions
Cyclophosphamide
39
Docetaxel
30
Tamoxifen
29
Paclitaxel
27
Doxorubicin
26
Trastuzumab
20
Radiotherapy
18
Epirubicin
16
Letrozole
13
exemestane
11
Fluorouracil
11
Anastrozole
11
Capecitabine
10
Bevacizumab
10
Immunohistochemistry
9
Filgrastim
9
Fulvestrant
8
Methotrexate
7
Gene Expression Profiling
7
palbociclib
6
Zoledronic Acid
6
Microarray Analysis
6
Lapatinib
6
Goserelin
6
Chemotherapy, Adjuvant
6
Amplified Fragment Length Polymorphism Analysis
6
Vinorelbine
5
Triptorelin Pamoate
5
Carboplatin
5
Absorptiometry, Photon
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Breast Neoplasms
×
Mesna
×
Clear all
NCT00002784
2013-04-04
15-95
ETOP IBCSG Partners Foundation
Phase 3
Completed
344 enrolled